针对个性化癌症治疗的nectin-4向辐射疗法:系统性审查
Laura Schäfer1, Betül Altunay1, Agnieszka Morgenroth1
1Department of Nuclear Medicine, University Hospital RWTH Aachen, Aachen, Germany.
概括
结核素细胞粘附分子4 (结核素-4) 是癌症治疗学的一个有希望的目标. 针对 nektin-4 的新型放射性追踪剂对瘤具有很高的特异性,有助于诊断和治疗监测.
科学领域:
- 在瘤学瘤学.
- 核医学是一种核医学.
- 分子成像学分子成像学
背景情况:
- 分子向疗法在瘤学中至关重要.
- 在恶性瘤中,nectin细胞粘附分子4 (nectin-4) 过度表达,与瘤进展有关.
- 尼克-4是尿路癌中抗体-药物合物的关键标.
研究的目的:
- 审查近期在素-4指导的分子治疗术的发展.
- 专注于设计,临床前验证和临床翻译新型放射性追踪剂.
- 为突出nectin-4作为成像和治疗的生物标志物.
主要方法:
- 关于素-4导向的分子治疗术的文献分析.
- 专注于基于抗体和的放射性追踪器的设计和验证.
- 对诊断准确性和治疗监测的临床前和临床数据的审查.
主要成果:
- 多个nectin-4向的放射标志物对瘤具有很高的特异性和亲和力 (骨髓癌,三阴性乳腺癌).
- 射线追踪器的诊断准确度与标准方法 (如[18F]FDG-PET.等) 的诊断准确度相当.
- 观察到更好地检测转移性病变,并有效监测治疗反应和耐药性.
结论:
- 尼克-4是分子成像和癌症治疗的有价值的标.
- 尼克-4向的放射性追踪剂提供了一个有前途的罗学方法.
- 这些药物有助于进行非侵入性瘤表征和治疗反应评估.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K


